Literature DB >> 23742995

A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens.

G A M Berbers1, M S E van de Wetering, P G M van Gageldonk, J F P Schellekens, F G A Versteegh, P F M Teunis.   

Abstract

We studied the time course of serum IgG antibodies against 3 different pertussis vaccine antigens: PT (pertussis toxin), FHA (filamentous hemagglutinin), Prn (pertactin) in sera from individuals vaccinated with four different pertussis vaccines at 4 years of age: (N=44, 44, 23 and 23, respectively,) and compared the responses to/after natural infection with Bordetella pertussis (N=44, age 1-8 years). These longitudinal data were analyzed with a novel method, using a mathematical model to describe the observed responses, and their variation among subjects. This allowed us to estimate biologically meaningful characteristics of the serum antibody response, like peak level and decay rate, and to compare these among natural infections and vaccine responses. Compared to natural infection, responses to PT after vaccination with the tested vaccines are smaller in magnitude and tend to decay slightly faster. When present in vaccines, FHA and Prn tend to produce high peak levels, higher than those in naturally infected patients, but these decay faster. As expected, the Dutch whole cell vaccine produced lower antibody responses than the acellular vaccines. This model allows a better comparison of the kinetics of vaccine induced antibody responses and after natural infection over a long follow up period.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acellular; Infection; Mixed model; Pertussis; Serology; Vaccine; Whole cell

Mesh:

Substances:

Year:  2013        PMID: 23742995     DOI: 10.1016/j.vaccine.2013.05.073

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination.

Authors:  Rose-Minke Schure; Lotte H Hendrikx; Lia G H de Rond; Kemal Oztürk; Elisabeth A M Sanders; Guy A M Berbers; Anne-Marie Buisman
Journal:  Clin Vaccine Immunol       Date:  2013-07-03

Review 2.  No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines.

Authors:  Thomas C Mitchell; Carolyn R Casella
Journal:  Curr Opin Immunol       Date:  2017-07-17       Impact factor: 7.486

3.  The vaccine potential of Bordetella pertussis biofilm-derived membrane proteins.

Authors:  Daan de Gouw; Diego O Serra; Marien I de Jonge; Peter Wm Hermans; Hans Jct Wessels; Aldert Zomer; Osvaldo M Yantorno; Dimitri A Diavatopoulos; Frits R Mooi
Journal:  Emerg Microbes Infect       Date:  2014-08-20       Impact factor: 7.163

Review 4.  Old Disease and New Challenges: Major Obstacles of Current Strategies in the Prevention of Pertussis.

Authors:  Iraj Sedighi; Abdollah Karimi; Ali Amanati
Journal:  Iran J Pediatr       Date:  2016-06-12       Impact factor: 0.364

5.  Impact of age and vaccination history on long-term serological responses after symptomatic B. pertussis infection, a high dimensional data analysis.

Authors:  Inonge van Twillert; Axel A Bonačić Marinović; Betsy Kuipers; Jacqueline A M van Gaans-van den Brink; Elisabeth A M Sanders; Cécile A C M van Els
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

6.  Enhanced Bordetella pertussis acquisition rate in adolescents during the 2012 epidemic in the Netherlands and evidence for prolonged antibody persistence after infection.

Authors:  Saskia van der Lee; Susanne P Stoof; Mariette B van Ravenhorst; Pieter G M van Gageldonk; Nicoline A T van der Maas; Elisabeth A M Sanders; Anne-Marie Buisman; Guy A M Berbers
Journal:  Euro Surveill       Date:  2017-11

7.  Antibody Specificity Following a Recent Bordetella pertussis Infection in Adolescence Is Correlated With the Pertussis Vaccine Received in Childhood.

Authors:  René H M Raeven; Larissa van der Maas; Jeroen L A Pennings; Kurt Fuursted; Charlotte Sværke Jørgensen; Elly van Riet; Bernard Metz; Gideon F A Kersten; Tine Dalby
Journal:  Front Immunol       Date:  2019-06-17       Impact factor: 7.561

8.  Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization.

Authors:  Edith Acquaye-Seedah; Elizabeth E Reczek; Hugh H Russell; Andrea M DiVenere; Sara O Sandman; Joseph H Collins; Caitlin A Stein; Timothy A Whitehead; Jennifer A Maynard
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

9.  Different Long-Term Duration of Seroprotection against Neisseria meningitidis in Adolescents and Middle-Aged Adults after a Single Meningococcal ACWY Conjugate Vaccination in The Netherlands.

Authors:  Milou Ohm; Debbie M van Rooijen; Axel A Bonačić Marinović; Mariëtte B van Ravenhorst; Marieke van der Heiden; Anne-Marie Buisman; Elisabeth A M Sanders; Guy A M Berbers
Journal:  Vaccines (Basel)       Date:  2020-10-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.